Emergent BioSolutions Inc.EBSNYSE
Loading
Cash generated from core business operations
5Y CAGR
-20.5%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $170.60M | +190.6% |
| 2024 | $58.70M | +128.5% |
| 2023 | $-206.30M | -505.0% |
| 2022 | $-34.10M | -110.6% |
| 2021 | $321.10M | -40.2% |
| 2020 | $536.90M | +185.6% |
| 2019 | $188.00M | +349.8% |
| 2018 | $41.80M | -79.9% |
| 2017 | $208.14M | +289.1% |
| 2016 | $53.49M | - |